Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

PC Connection Stock: Growth Meets Margin Pressure in Q2 2025

Dieter Jaworski by Dieter Jaworski
August 19, 2025
in Stocks
0
PC Connection Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Technology solutions provider PC Connection presents investors with a complex investment case following its second-quarter 2025 results. While the company reported modest revenue growth, shrinking profitability metrics raise questions about its ability to maintain momentum in a competitive hardware market.

Financial Performance: A Tale of Two Metrics

The New Hampshire-based firm posted $759.7 million in net sales for Q2 2025, marking a 3.2% year-over-year increase. This growth stemmed primarily from data center modernization projects and enterprise transitions to Windows 11 systems. Gross profit saw marginal improvement, rising 0.9% to $137.8 million.

However, beneath these positive figures lurk concerning trends:

  • Net income declined 5.2% to $24.8 million
  • Gross margin contracted by 40 basis points to 18.1%
  • Earnings per share remained flat at $0.97

Segment performance revealed stark contrasts:

  • Business Solutions Division: Revenue climbed 5.4% to $293.2 million with gross profit up 3.8% ($68.8 million)
  • Public Sector Unit: Sales plummeted 11.9%, reflecting weakening government demand

Shareholder Returns Defy Operational Challenges

Despite these headwinds, management continues returning capital to investors through:

Should investors sell immediately? Or is it worth buying PC Connection?

  • A quarterly dividend of $0.15 per share payable August 29
  • Substantial share repurchases totaling $106.11 million (1.83 million shares) during the quarter

This aggressive buyback program represents approximately 4% of outstanding shares at current valuations.

Technical Indicators Flash Caution Signals

Market technicians observe multiple warning signs in PC Connection’s stock performance:

  • 19 out of 26 technical indicators turned bearish as of August 14
  • The emergence of a KDJ death cross and bearish marubozu pattern suggests continued downward momentum
  • Shares currently trade between $62.37 and $63.59, slightly above the 52-week low of $56.72 hit August 8
  • Weekly and monthly losses stand at 3.35% and 3.04% respectively (through July 31)

Notably, trading volumes exceeded 208,000 shares during recent sell-offs, indicating heightened investor anxiety. Market participants now watch closely to determine whether current levels represent a consolidation phase or the beginning of a sustained downtrend.

The coming quarters will prove critical for PC Connection as it balances growth initiatives against margin preservation in an increasingly price-sensitive technology hardware environment.

Ad

PC Connection Stock: Buy or Sell?! New PC Connection Analysis from March 25 delivers the answer:

The latest PC Connection figures speak for themselves: Urgent action needed for PC Connection investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

PC Connection: Buy or sell? Read more here...

Tags: PC Connection
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Netflix Stock

Netflix Posts Stellar Earnings But Fails to Impress Investors

Assembly Biosciences Stock

Biotech Stock Assembly Biosciences Receives Bullish $50 Price Target from H.C. Wainwright

Oracle Stock

Oracle's AI Ambition Collides With Workforce Restructuring

Recommended

BigBearai Holdings Stock

BigBear.ai Faces Critical Test as Revenue Plummets and Losses Mount

6 months ago
D-Wave Quantum Stock

D-Wave Quantum: CFO’s Multi-Million Dollar Exit Amidst Major Capital Raise

4 months ago
Brightcove Stock

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

6 months ago
Microsoft Stock

Microsoft Faces Critical Earnings Test Amid AI Expectations

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

Trending

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

by SiterGedge
March 25, 2026
0

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant...

Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon
  • Ocugen Shares Slide Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com